ClinicalTrials.Veeva

Menu

Feasibility of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention Deficit Disorder (ADD). (BMST)

T

Tel Aviv Sourasky Medical Center

Status and phase

Unknown
Phase 1

Conditions

Adult Attention Deficit Disorder

Treatments

Device: Transcranial Direct Current Stimulation

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02206516
0214-14

Details and patient eligibility

About

This study aims at combining imaging techniques and clinical evaluations to assess clinical change as well as brain changes that occur as a result of brain stimulation in adult attention deficit disorder.

Full description

This study will use clinical measures and cognitive tasks covering 3 different functional domains during functional magnetic resonance imaging (fMRI), ElectroEncephaloGram (EEG) and Ultrasound tagged near infrared spectroscopy (UT-NIRS), to assess functional brain changes as a result of a treatment protocol with Transcaranial direct current stimulation (tDCS) in adults suffering from attention deficit disorder (ADD).

Enrollment

20 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Patients between the ages of 18-65(male and female)
  2. Diagnosed as suffering from Attention-Deficit Hyperactivity Disorder according to the DSM IV
  3. Patients taking medication for ADHD will give their consent to stop those medication 48 before entering the study and throughout the daily treatments.
  4. Gave informed consent for participation in the study
  5. If referred by the treating psychiatrist, he or she approves of the subjects participation in the study

Exclusion criteria

  1. Suffering from other diagnosis on axis 1
  2. History of drug or alcohol abuse during the last year
  3. Inability to achieve satisfying level of communication with the subject

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

patients
Experimental group
Description:
Stimulation using tDCS will be administered daily, 5 days a week for 4 weeks. each session will last 22 minutes during which the anode electrode will be positioned over the right Inferior Frontal Gyrus (IFG) and the Katode electrode over the right Orbito Frontal Gyrus (OFG).
Treatment:
Device: Transcranial Direct Current Stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems